3D Ballistocardiography in Microgravity
B3D
1 other identifier
interventional
18
1 country
1
Brief Summary
3-D Ballistocardiography (BCG) recording was performed in microgravity during the Spacelab D2 missions on a single astronaut. The results from this experiment have been published in the literature: the influence of respiration have been demonstrated and the signal processing methodology for the reconstruction of the displacement in one cardiac cycle have been developed. A 3D-BCG sensor has been developed and a collaboration to perform a sustained microgravity experiment onboard the Russian segment of ISS has been initiated. To be integrated in the PNEUMOCARD device, this new sensor needs to be tested in microgravity before implemented on ISS. The aim of the present parabolic flight study is to serve as a feasibility demonstrator and test bed in order to evaluate the feasibility of 3D-BCG in sustained microgravity and to test whether the sensitivity of the developed 3D-BCG sensor is appropriate
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2011
CompletedFirst Submitted
Initial submission to the registry
July 23, 2015
CompletedFirst Posted
Study publicly available on registry
August 6, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2015
CompletedAugust 6, 2015
August 1, 2015
3.8 years
July 23, 2015
August 5, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Heart rate
evaluated by BCG, ECG, ICG and echocardiography during the free-floating protocol
baseline
stroke volume
evaluated by BCG, ECG, ICG and echocardiography during the free-floating protocol
baseline
ejection fraction
evaluated by BCG, ECG, ICG and echocardiography during the free-floating protocol
baseline
Study Arms (1)
Cardiovascular parameters measurements
OTHERInterventions
with Ballistocardiography (BCG), electric cardiography (ECG), impedance cardiography (ICG) and echocardiography
Eligibility Criteria
You may qualify if:
- Healthy volunteers (men or women)
- Aged from 18 to 65
- Affiliated to a Social Security system and, for non-French resident, holding a European Health Insurance Card (EHIC)
- Who accepted to take part in the study
- Who have given their written stated consent
- Whose 4 chamber view of the heart during a breath hold is easy to get during a routine cardiac echocardiography (M-Mode - apical view).
- Who has passed a medical examination similar to a standard aviation medical examination for private pilot aptitude (JAR FCL3 Class 2 medical examination). There will be no additional test performed for subject selection.
You may not qualify if:
- Difficulty to obtain a clear echocardiography.
- Pregnant women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Umr Ucbn/Inserm U1075 Comete
Caen, Basse-Normandie, 14032, France
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 23, 2015
First Posted
August 6, 2015
Study Start
December 1, 2011
Primary Completion
October 1, 2015
Last Updated
August 6, 2015
Record last verified: 2015-08